Clesrovimab: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Clesrovimab. Educational only — not medical advice.
Labeled uses
ENFLONSIA is indicated for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and infants who are born during or entering their first RSV season.
Source: FDA labeling via NIH DailyMed (set c9004a92…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.